Grenada vs Jamaica: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Grenada
0.2%
in 2024
Jamaica
0.2%
in 2024
Grenada rank
78th
Jamaica rank
78th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Grenada
- Jamaica
How they compare
Grenada currently reports 0.2% against 0.2% in Jamaica, a difference of 0.0%.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Grenada ahead.
Grenada ranks 78th and Jamaica ranks 78th of 215 countries.
Head to head by decade
| Decade | Grenada | Jamaica | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.3% | 0.0% | — |
| 2020s | 0.2% | 0.2% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Grenada or Jamaica?
- Grenada, at 0.2% against 0.2% in Jamaica as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Grenada and Jamaica?
- 0.0%, with Grenada ahead.
- How many years of comparable data are there for Grenada and Jamaica?
- 10 years are reported by both, from 2015 to 2024.
- How do Grenada and Jamaica rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Grenada ranks 78th and Jamaica ranks 78th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.